Brief: Adalta Ltd Says Received Approval To Commence A Phase I Extension Clinical Study Of AD-214
29/06/2023 24:59
June 29 (Reuters) - Adalta Ltd 1AD.AX :
* RECEIVED HUMAN RESEARCH ETHICS COMMITTEE APPROVAL TO
COMMENCE A
PHASE I EXTENSION CLINICAL STUDY OF AD-214
Source text for Eikon: ID:nASX3JvTFq
Further company coverage: 1AD.AX
((Reuters.Briefs@thomsonreuters.com;))